Transforming Antibody Therapy
People
Latest news
27 Feb, 2025
Sorriso Pharmaceuticals Presents Positive SOR102 Phase 1b Ulcerative Colitis Data at ECCO Conference
27 Feb, 2025
Startup working on oral antibodies shares early ulcerative colitis data
19 Dec, 2024
Sorriso Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results for SOR102 in Ulcerative Colitis
19 Dec, 2024
Exclusive: Can oral antibodies work? A small startup thinks it has an answer
3 Sep, 2024
Sorriso Pharmaceuticals Completes Enrollment in Phase 1b Clinical Trial of Patients with Ulcerative Colitis
17 May, 2024
Sorriso Pharmaceuticals Announces First Patients Dosed in Phase 1b Clinical Trial for Patients with Ulcerative Colitis